Resolvin E1 (RvE1), derived from EPA (omega-3), and other lipid mediators play a role in inflammation-associated models of arthritis (235) by modulating Cyclooxygenase 2 (COX-2) activity. This evidence concerns the gene PTGS2 and arthritic joint disease.